Biogen Sees Positive Results From Study of Potential Multiple Sclerosis Treatment

Published January 24, 2013

Biogen Sees Positive Results From Study of Potential Multiple Sclerosis Treatment

Filed under: outpatient drug treatment programs

And in October, Biogen reported its third-quarter earnings rose 13% as the biopharmaceutical company saw growth of its biggest drug, multiple-sclerosis treatment Avonex, and received a boost from a gain tied to Benlysta. Shares closed Wednesday at …
Read more on NASDAQ

Transfusions wane: Drug Lance Armstrong used can also help eliminate need …

Filed under: outpatient drug treatment programs

Ontario is saving an estimated $ 39-million a year in the cost of collecting, storing and administering blood and treating the complications of transfusion, said Dr. John Freedman, medical director of the OnTrac program. Ontario has been at the …
Read more on National Post